David Shaw’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.18M | Sell |
231,000
-3,800
| -2% | -$34.1K | ﹤0.01% | 3130 |
|
|
2026
Q1 | $1.91M | Sell |
234,800
-31,400
| -12% | -$285K | ﹤0.01% | 2959 |
|
|
2025
Q4 | $1.79M | Sell |
266,200
-4,800
| -2% | -$36.2K | ﹤0.01% | 3136 |
|
|
2025
Q3 | $2.35M | Buy |
271,000
+3,800
| +1% | +$29.6K | ﹤0.01% | 2856 |
|
|
2025
Q2 | $1.68M | Buy |
267,200
+230,400
| +626% | +$1.53M | ﹤0.01% | 2870 |
|
|
2025
Q1 | $236K | Sell |
36,800
-126,700
| -77% | -$1.05M | ﹤0.01% | 3862 |
|
|
2024
Q4 | $1.31M | Sell |
163,500
-113,200
| -41% | -$1.09M | ﹤0.01% | 3040 |
|
|
2024
Q3 | $3.49M | Buy |
276,700
+42,100
| +18% | +$544K | ﹤0.01% | 2242 |
|
|
2024
Q2 | $2.97M | Buy |
234,600
+154,400
| +193% | +$1.55M | ﹤0.01% | 2267 |
|
|
2024
Q1 | $383K | Sell |
80,200
-231,900
| -74% | -$1.08M | ﹤0.01% | 3610 |
|
|
2023
Q4 | $1.5M | Hold |
312,100
| – | – | ﹤0.01% | 2874 |
|
|
2023
Q3 | $2.26M | Buy |
312,100
+60,200
| +24% | +$481K | ﹤0.01% | 2470 |
|
|
2023
Q2 | $1.87M | Hold |
251,900
| – | – | ﹤0.01% | 2671 |
|
|
2023
Q1 | $1.75M | Sell |
251,900
-566,000
| -69% | -$5.21M | ﹤0.01% | 2787 |
|
|
2022
Q4 | $8.41M | Buy |
817,900
+605,900
| +286% | +$10.7M | 0.01% | 1597 |
|
|
2022
Q3 | $3.86M | Buy |
212,000
+51,900
| +32% | +$2.25M | ﹤0.01% | 2373 |
|
|
2022
Q2 | $8.23M | Buy |
160,100
+10,000
| +7% | +$518K | 0.01% | 1569 |
|
|
2022
Q1 | $11.1M | Sell |
150,100
-3,100
| -2% | -$276K | 0.01% | 1511 |
|
|
2021
Q4 | $21.9M | Sell |
153,200
-10,100
| -6% | -$1.74M | 0.02% | 1019 |
|
|
2021
Q3 | $33.9M | Sell |
163,300
-43,000
| -21% | -$9.48M | 0.03% | 719 |
|
|
2021
Q2 | $43.8M | Buy |
206,300
+20,000
| +11% | +$3.66M | 0.04% | 614 |
|
|
2021
Q1 | $33.8M | Buy |
186,300
+75,700
| +68% | +$15.1M | 0.03% | 664 |
|
|
2020
Q4 | $12.3M | Sell |
110,600
-63,800
| -37% | -$6.78M | 0.01% | 1244 |
|
|
2020
Q3 | $18.9M | Buy |
174,400
+124,400
| +249% | +$15.2M | 0.02% | 863 |
|
|
2020
Q2 | $4.17M | Buy |
+50,000
| New | +$1.91M | 0.01% | 1791 |
|
|
2018
Q1 | – | Sell |
-2,500
| Closed | -$62K | – | 3698 |
|
|
2017
Q4 | $62K | Hold |
2,500
| – | – | ﹤0.01% | 3524 |
|
|
2017
Q3 | $57K | Hold |
2,500
| – | – | ﹤0.01% | 3399 |
|
|
2017
Q2 | $57K | Hold |
2,500
| – | – | ﹤0.01% | 3302 |
|
|
2017
Q1 | $64K | Hold |
2,500
| – | – | ﹤0.01% | 3217 |
|
|
2016
Q4 | $63K | Hold |
2,500
| – | – | ﹤0.01% | 3369 |
|
|
2016
Q3 | $104K | Buy |
+2,500
| New | +$323K | ﹤0.01% | 3283 |
|
Other funds holding NVAX
SCM
S
David Shaw's NVAX Position: Q2 2026 in Review
David Shaw reduced its Novavax (NVAX) stake by 27% in Q2 2026, selling an estimated $18.4M and leaving 5,650,905 shares worth $53.2M. The position accounts for 0.03% of the portfolio, ranked #730.
David Shaw first reported a position in NVAX in Q2 2013 and has held it in 48 quarters since. The position peaked at $82.9M in Q2 2020. 264 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- David Shaw held 5,650,905 shares of Novavax worth $53.2M as of Q2 2026.
- David Shaw sold 2,058,953 Novavax shares in Q2 2026, an estimated $18.4M.
- Novavax made up 0.03% of David Shaw's portfolio in Q2 2026, its #730 holding.
- David Shaw first reported a position in Novavax in Q2 2013 and has held it in 48 quarters since.
- David Shaw's Novavax position peaked at $82.9M in Q2 2020.
- 264 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.